Patent · Technology Assets

Evidence-First Research Principles

PILLEDAY focuses on mechanisms, not marketing. Following three design principles established by a rehabilitation medicine specialist, we formulate only research-validated ingredients, and only at effective doses.

• EVIDENCE Evidence-first We select and blend only ingredients validated in published research.
• HIGH-DOSE Effective dosage We insist on the maximum amounts allowed under MFDS and clinical standards.
• SYNERGY Absorption by design We apply formulas that prevent conflicts between ingredients and improve absorption.

Core Technologies

• Tablet dispensing technology Core technology that dispenses supplements precisely from a cartridge — design complete.
• Grinding technology Core technology for uniform grinding and compounding from powder cartridges — design complete.

Patent Portfolio 4 patents

• 01
  Personalized supplement compounding system 10-2023-0112572 · 2023.08.28
• 02
  Personalized supplement compounding system capable of compounding supplements matched to user characteristics 10-2024-0099921 · 2024.07.29
• 03
  Composition for improving memory and concentration 10-2024-0103097 · 2024.08.02
• 04
  Behavior-data-based personalized supplement prescription system 10-2025-0128606 · 2025.09.09

Alongside our 4 patents we hold 8 trademarks, for a total of 12 intellectual property rights.

Trademark Portfolio 8 trademarks

• PILLEDAY
• 필리데이
• 닥터NMN300
• 닥터 포스파티딜세린 징코
• 모닝부스터

We hold 8 registered trademarks in total, covering the PILLEDAY brand and our product names.

Certifications & Achievements

• Named a 2025 K-Unicorn Outstanding Company
• Selected for the Busan Youth Startup Academy
• Selected for the IP Narae Program
• Selected for the Busanjin-gu IP Creation Support Program
• Selected for Busan Technology Startup Incubating
• Selected for Sports Accelerating
• Selected for Inje University Youth Startup Activation
• Selected as a Glocal Startup
• Cumulative Wadiz funding rate of 17,069%